Lenvatinib plus pembrolizumab in patients with renal cell carcinoma: Updated results Meeting Abstract


Authors: Lee, C. H.; Makker, V.; Rasco, D. W.; Taylor, M. H.; Stepan, D. E.; Shumaker, R. C.; Schmidt, E. V.; Guo, M.; Dutcus, C. E.; Motzer, R. J.
Abstract Title: Lenvatinib plus pembrolizumab in patients with renal cell carcinoma: Updated results
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 256s
Language: English
ACCESSION: WOS:000442916002087
DOI: 10.1200/JCO.2018.36.15_suppl.4560
PROVIDER: wos
Notes: Meeting Abstract: 4560 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Vicky Makker
    263 Makker
  2. Robert Motzer
    1243 Motzer
  3. Chung-Han   Lee
    157 Lee